Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia

Clinical trial NCT02540655 · COMPLETED

Trial details

NCT number: NCT02540655
Sponsor: Steminent Biotherapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cerebellar Ataxia

Start date: 2015-09-01
Primary completion: 2021-02-26
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.